Drug Delivery & Development
  • Article
  • Mar 29 2018

New findings from University of Kentucky researchers published in Nature Chemical Biology help reveal how nature makes complex chemicals with anticancer properties.

  • Article
  • Mar 29 2018

UK researchers are participating in a project to grow a plant which can be used in medications to fight malaria.

  • Article
  • Feb 26 2018

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

  • Article
  • Dec 21 2017

Led by a multidisciplinary team of clinicians and scientists, the studies aim to develop new treatments using existing therapies that protect brain tissue after a stroke, and to learn more about the physiology of the event.

  • Podcast
  • Nov 9 2017

Kip Guy shares his research on neglected diseases, his goals as dean of the College of Pharmacy, and how pharmacy researchers are addressing the opioid epidemic.

  • Video
  • Oct 6 2017

The National Institutes of Health has awarded a five year, $2.88 million grant to a researcher at the Sanders-Brown Center on Aging to study a drug's potential to prevent Alzheimer's disease.

  • Article
  • Aug 29 2017

~$5 million in additional funding from the Global Health Innovative Technology Fund (GHIT) has been awarded to the lab of Dean Kip Guy at the University of Kentucky College of Pharmacy, in partnership with Eisai Pharmaceuticals and Medicines for Malaria Venture (MMV), for ongoing malaria research.

  • Video
  • Aug 24 2017

Kip Guy, Pharmacy Dean, is discovering and developing new drugs for neglected diseases.

  • Article
  • Aug 18 2017

Yinan Wei, associate professor of chemistry at the University of Kentucky, has received an award to study membrane protein oligomerizations in bilayers. The project also integrates an outreach program for girls aged 12-18 at the Hope Hill Youth Service, introducing science and science careers.

  • Video
  • Nov 16 2016

Steven Van Lanen is hoping to find new antibiotic chemistry that defies drug resistance.